Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase - PubMed (original) (raw)
. 1999 Mar 4;398(6722):84-90.
doi: 10.1038/18050.
Affiliations
- PMID: 10078535
- DOI: 10.1038/18050
Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase
W Meng et al. Nature. 1999.
Abstract
Cbl is an adaptor protein that functions as a negative regulator of many signalling pathways that start from receptors at the cell surface. The evolutionarily conserved amino-terminal region of Cbl (Cbl-N) binds to phosphorylated tyrosine residues and has cell-transforming activity. Point mutations in Cbl that disrupt its recognition of phosphotyrosine also interfere with its negative regulatory function and, in the case of v-cbl, with its oncogenic potential. In T cells, Cbl-N binds to the tyrosine-phosphorylated inhibitory site of the protein tyrosine kinase ZAP-70. Here we describe the crystal structure of Cbl-N, both alone and in complex with a phosphopeptide that represents its binding site in ZAP-70. The structures show that Cbl-N is composed of three interacting domains: a four-helix bundle (4H), an EF-hand calcium-binding domain, and a divergent SH2 domain that was not recognizable from the amino-acid sequence of the protein. The calcium-bound EF hand wedges between the 4H and SH2 domains and roughly determines their relative orientation. In the ligand-occupied structure, the 4H domain packs against the SH2 domain and completes its phosphotyrosine-recognition pocket. Disruption of this binding to ZAP-70 as a result of structure-based mutations in the 4H, EF-hand and SH2 domains confirms that the three domains together form an integrated phosphoprotein-recognition module.
Comment in
- An SH2 domain in disguise.
Kuriyan J, Darnell JE Jr. Kuriyan J, et al. Nature. 1999 Mar 4;398(6722):22-3, 25. doi: 10.1038/17916. Nature. 1999. PMID: 10078523 No abstract available.
Similar articles
- A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells.
Lupher ML Jr, Reedquist KA, Miyake S, Langdon WY, Band H. Lupher ML Jr, et al. J Biol Chem. 1996 Sep 27;271(39):24063-8. doi: 10.1074/jbc.271.39.24063. J Biol Chem. 1996. PMID: 8798643 - Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
Sawasdikosol S, Chang JH, Pratt JC, Wolf G, Shoelson SE, Burakoff SJ. Sawasdikosol S, et al. J Immunol. 1996 Jul 1;157(1):110-6. J Immunol. 1996. PMID: 8683103 - Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
Narula SS, Yuan RW, Adams SE, Green OM, Green J, Philips TB, Zydowsky LD, Botfield MC, Hatada M, Laird ER, et al. Narula SS, et al. Structure. 1995 Oct 15;3(10):1061-73. doi: 10.1016/s0969-2126(01)00242-8. Structure. 1995. PMID: 8590001 - The Cbl family of signal transduction molecules.
Smit L, Borst J. Smit L, et al. Crit Rev Oncog. 1997;8(4):359-79. doi: 10.1615/critrevoncog.v8.i4.50. Crit Rev Oncog. 1997. PMID: 9622055 Review. - The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
Miyake S, Lupher ML Jr, Andoniou CE, Lill NL, Ota S, Douillard P, Rao N, Band H. Miyake S, et al. Crit Rev Oncog. 1997;8(2-3):189-218. doi: 10.1615/critrevoncog.v8.i2-3.30. Crit Rev Oncog. 1997. PMID: 9570294 Review.
Cited by
- c-Cbl is not required for ERK1/2-dependent degradation of BimEL.
Wiggins CM, Band H, Cook SJ. Wiggins CM, et al. Cell Signal. 2007 Dec;19(12):2605-11. doi: 10.1016/j.cellsig.2007.08.008. Epub 2007 Aug 23. Cell Signal. 2007. PMID: 17884340 Free PMC article. - Combining multiple structure and sequence alignments to improve sequence detection and alignment: application to the SH2 domains of Janus kinases.
Al-Lazikani B, Sheinerman FB, Honig B. Al-Lazikani B, et al. Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14796-801. doi: 10.1073/pnas.011577898. Proc Natl Acad Sci U S A. 2001. PMID: 11752426 Free PMC article. - A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase.
Thien CB, Scaife RM, Papadimitriou JM, Murphy MA, Bowtell DD, Langdon WY. Thien CB, et al. J Exp Med. 2003 Feb 17;197(4):503-13. doi: 10.1084/jem.20021498. J Exp Med. 2003. PMID: 12591907 Free PMC article. - Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders.
Naramura M, Nadeau S, Mohapatra B, Ahmad G, Mukhopadhyay C, Sattler M, Raja SM, Natarajan A, Band V, Band H. Naramura M, et al. Oncotarget. 2011 Mar;2(3):245-50. doi: 10.18632/oncotarget.233. Oncotarget. 2011. PMID: 21422499 Free PMC article. - Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction.
Liu CS, Yang-Yen HF, Suen CS, Hwang MJ, Yen JJ. Liu CS, et al. Sci Rep. 2017 Jul 4;7(1):4613. doi: 10.1038/s41598-017-04078-w. Sci Rep. 2017. PMID: 28676638 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous